Agree. My previous post about small trial that was only to say that trial was small to derive any conclusion but it may be appropriate for safety or efficacy signals as you mentioned.
In my previous post I spend lot of time about when was the product taken over by OSL and if i am not wrong it was 10 or 9 year ago and all they did was this one trial nothing else. All blame to previous board obviously (we still have one director left on board from previous team and hopefully he resign from board before next AGM).
As much as I have confidence on technical and past experience capability of Nigel and his team, In my opinion board is still not open and transparent about lack of sell in EU & UK... that is what worries me more then anything.
OSL Price at posting:
4.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)